Protagonist Therapeutics Inc logo

Protagonist Therapeutics Inc

NEW
NAS:PTGX (USA)  
$ 155.17 +3.68 (+2.43%) 10:08 PM EST
150.65
P/B:
11.93
Market Cap:
$ 10.04B
Enterprise V:
$ 9.27B
Volume:
426.25K
Avg Vol (2M):
728.84K
Trade In:
Volume:
426.25K
Avg Vol (2M):
728.84K

Protagonist Therapeutics Inc (PTGX) Dividend

Protagonist Therapeutics Inc (PTGX) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -8.2%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: PTGX Dividend

Does Protagonist Therapeutics Inc (PTGX) pay a dividend?

Protagonist Therapeutics Inc (PTGX) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Protagonist Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Protagonist Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -8.2% over the past 3 years.

What are dividend-paying alternatives to Protagonist Therapeutics Inc?

For dividend-paying alternatives in Protagonist Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.